Clinical Research Directory
Browse clinical research sites, groups, and studies.
Outcomes From Point-of-Care Sexually Transmitted Infection (STI) Testing in an Urban Sexual Health Clinic: A Randomized Trial
Sponsor: Massachusetts General Hospital
Summary
The goal of this clinical trial is to learn about the impact of a point-of-care test for gonorrhea and chlamydia in people without symptoms who are seeking sexually transmitted infection testing. The main questions it aims to answer are: Does the point of care test reduce the time to antibiotic treatment? Does the point of care test increase the number of people who have completed treatment by day 7? Researchers will compare the point-of-care test to a standard laboratory-based test for gonorrhea and chlamydia. Participants will be asked to provide a urine sample or vaginal swab for testing. They will also complete surveys about their experiences with the testing.
Official title: Outcomes From Point-of-Care STI Testing in an Urban Sexual Health Clinic: A Randomized Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2026-03
Completion Date
2027-02
Last Updated
2026-02-10
Healthy Volunteers
Yes
Interventions
Point-of-care assay for chlamydia and gonorrhea
This intervention consists of use of Cobas® Liat CT/NG Assay (Roche, United States).
Laboratory-based chlamydia and gonorrhea NAAT
This intervention consists of routine, laboratory-based diagnostic testing for chlamydia and gonorrhea via nucleic acid amplification.
CRISPR-based assay
This is a novel assay using CRISPR technology to assess for STIs and antimicrobial resistance.